These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 39342097)

  • 1. Metabolic and Immunological Implications of MME
    Wang B; Pan Y; Xie Y; Wang C; Yang Y; Sun H; Yan Z; Cui Y; Li L; Zhou Y; Liu W; Pan Z
    Biol Proced Online; 2024 Sep; 26(1):29. PubMed ID: 39342097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer.
    Peiffer R; Boumahd Y; Gullo C; Crake R; Letellier E; Bellahcène A; Peulen O
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer.
    Zhou P; Du X; Jia W; Feng K; Zhang Y
    Signal Transduct Target Ther; 2024 Jun; 9(1):151. PubMed ID: 38910148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients.
    Li K; Wang R; Liu GW; Peng ZY; Wang JC; Xiao GD; Tang SC; Du N; Zhang J; Zhang J; Ren H; Sun X; Yang YP; Liu DP
    Sci Rep; 2024 Jul; 14(1):16766. PubMed ID: 39034310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer.
    Arebro J; Towle R; Lee CM; Bennewith KL; Garnis C
    Front Cell Dev Biol; 2023; 11():1240159. PubMed ID: 37745296
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
    Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
    Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.
    Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR
    Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer.
    Sebastian A; Hum NR; Martin KA; Gilmore SF; Peran I; Byers SW; Wheeler EK; Coleman MA; Loots GG
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer.
    Morgan A; Griffin M; Kameni L; Wan DC; Longaker MT; Norton JA
    Biology (Basel); 2023 Jul; 12(8):. PubMed ID: 37626931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
    Chen B; Chan WN; Xie F; Mui CW; Liu X; Cheung AHK; Lung RWM; Chow C; Zhang Z; Fang C; Yu P; Shi S; Zhou S; Chen G; Wang Z; Wang S; Ding X; Huang B; Liang L; Dong Y; Wong CC; Wu WKK; Cheng ASL; Wong N; Yu J; Lo KW; Tse GMK; Kang W; To KF
    Clin Transl Med; 2023 Dec; 13(12):e1516. PubMed ID: 38148640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect.
    Hu X; Peng X; Zhang Y; Fan S; Liu X; Song Y; Ren S; Chen L; Chen Y; Wang R; Peng J; Shen X; Chen Y
    Phytomedicine; 2024 Jan; 123():155214. PubMed ID: 38134861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
    Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
    Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro.
    Miyazaki Y; Oda T; Mori N; Kida YS
    FEBS Open Bio; 2020 Nov; 10(11):2268-2281. PubMed ID: 32931156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer.
    Datta J; Dai X; Bianchi A; De Castro Silva I; Mehra S; Garrido VT; Lamichhane P; Singh SP; Zhou Z; Dosch AR; Messaggio F; Ban Y; Umland O; Hosein PJ; Nagathihalli NS; Merchant NB
    Gastroenterology; 2022 Dec; 163(6):1593-1612. PubMed ID: 35948109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.